Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival ; volume:24 ; number:1 ; day:18 ; month:12 ; year:2024 ; pages:1-11 ; date:12.2024
BMC cancer ; 24, Heft 1 (18.12.2024), 1-11, 12.2024
- Creator
-
Schmidt, Marieke
Vernooij, Robin
Nuland, Merel van
Smeijsters, Erin
Devriese, Lot
Mohammad, Nadia Haj
Hermens, Thom
Stammers, Julian
Swart, Christina
Egberts, Toine
Haitjema, Saskia
Lammers, Laureen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-13330-2
- URN
-
urn:nbn:de:101:1-2503010637141.235977283652
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schmidt, Marieke
- Vernooij, Robin
- Nuland, Merel van
- Smeijsters, Erin
- Devriese, Lot
- Mohammad, Nadia Haj
- Hermens, Thom
- Stammers, Julian
- Swart, Christina
- Egberts, Toine
- Haitjema, Saskia
- Lammers, Laureen
- SpringerLink (Online service)
Other Objects (12)
Severe skin toxicity due to weekly paclitaxel administration
A single institution experience with palbociclib toxicity requiring dose modifications
Crystal Structure and Toxicity of the Polymorphic Modifications of the Rodenticide Difenacin
Amyloid pathology reduces ELP3 expression and tRNA modifications leading to impaired proteostasis
Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells
Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma
Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models
Overall
Overall
Overall
Overall
Peptide backbone modifications of amyloid β (1–40) impact fibrillation behavior and neuronal toxicity
Severe skin toxicity due to weekly paclitaxel administration
A single institution experience with palbociclib toxicity requiring dose modifications
Crystal Structure and Toxicity of the Polymorphic Modifications of the Rodenticide Difenacin
Amyloid pathology reduces ELP3 expression and tRNA modifications leading to impaired proteostasis
Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells
Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma
Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models
Overall
Overall
Overall
Overall
Peptide backbone modifications of amyloid β (1–40) impact fibrillation behavior and neuronal toxicity
Severe skin toxicity due to weekly paclitaxel administration
A single institution experience with palbociclib toxicity requiring dose modifications
Crystal Structure and Toxicity of the Polymorphic Modifications of the Rodenticide Difenacin
Amyloid pathology reduces ELP3 expression and tRNA modifications leading to impaired proteostasis
Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells
Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma
Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models
Overall
Overall
Overall
Overall